Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1996
08/27/1996US5549897 High molecular weight surface proteins of non-typeable haemophilus
08/27/1996US5549896 For prophylaxis, diagnosis
08/27/1996US5549895 Method and colicin composition for inhibiting Escherichia coli 0157:H7 in food products
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025520A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996WO1996025519A1 Virulence-attenuating genetic deletions
08/22/1996WO1996025511A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
08/22/1996WO1996025507A2 Methods of preparation and use of recombinant adenoviral vectors
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025501A2 Method and composition for regulating apoptosis
08/22/1996WO1996025500A1 Genes coding for proteins having acyl transfer activity
08/22/1996WO1996025498A2 Mpl ligand analogs
08/22/1996WO1996025497A1 New chemokines expressed in pancreas
08/22/1996WO1996025496A1 PRODUCTION OF BIOLOGICALLY ACTIVE RECOMBINANT BOVINE FOLLICLE STIMULATING HORMONE (REC bFSH) IN THE BACULOVIRUS EXPRESSION SYSTEM
08/22/1996WO1996025495A1 Sperm factor
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025493A1 Multiple-tumor aberrant growth genes
08/22/1996WO1996025492A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
08/22/1996WO1996025487A1 Materials and methods relating to the regulation of polypeptide production in cells
08/22/1996WO1996025435A1 MONOCLONAL ANTIBODY SPECIFIC FOR βA4 PEPTIDE
08/22/1996WO1996025434A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
08/22/1996WO1996025433A1 B cell differentiation and proliferation factors and methods for obtaining and using the same
08/22/1996WO1996025432A1 Human g-protein coupled receptor
08/22/1996WO1996025431A1 Cancer-associated mar binding protein
08/22/1996WO1996025430A1 Helicobacter pylori antigen
08/22/1996WO1996025429A1 Insecticidal toxins from bracon hebetor
08/22/1996WO1996025427A1 Serine protease inhibitors
08/22/1996WO1996025425A1 Purified tetanus toxoid and toxin
08/22/1996WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025380A1 The use of tributyrin in the treatment of inflammatory bowel disease
08/22/1996WO1996025228A1 ADSORBENT FOR TUMOR NECROSIS FACTOR α, METHOD OF REMOVAL BY ADSORPTION, AND ADSORPTION DEVICE USING SAID ADSORBENT
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025173A1 Encapsidated recombinant poliovirus nucleic acid
08/22/1996WO1996025170A1 METHOD FOR TREATMENT OF DISEASE WITH ANTI-SIGMA FACTOR AsiA
08/22/1996WO1996025041A1 Insecticidal peptides from spider venom
08/22/1996WO1996019498A3 T cell stimulating protein of pestivirus
08/22/1996WO1996017941A3 Production of c-terminal amidated peptides from recombinant protein constructs
08/22/1996WO1996017935A3 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
08/22/1996WO1996015149A3 Methods and compositions for screening for presynaptic calcium channel blockers
08/22/1996DE19605657A1 Proinsulinderivat und Verfahren zur Herstellung von menschlichem Insulin Proinsulin derivative and process for the preparation of human insulin
08/22/1996DE19522171C1 Competitive immunoassay for auto-antibodies against thyroid stimulating hormone receptor
08/22/1996DE19504776A1 Thrombin-inhibiting protein
08/22/1996CA2430223A1 Keratinocyte growth factor-2
08/22/1996CA2223125A1 Production of biologically active recombinant bovine follicle stimulating hormone (recbfsh) in the baculovirus expression system
08/22/1996CA2213444A1 Insecticidal toxins from bracon hebetor
08/22/1996CA2213443A1 Insecticidal peptides from spider venom
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213237A1 Multiple-tumor aberrant growth genes
08/22/1996CA2213229A1 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
08/22/1996CA2213132A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996CA2212952A1 Helicobacter pylori antigen
08/22/1996CA2212830A1 Serine protease inhibitors
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2211101A1 Materials and methods relating to the regulation of polypeptide production in cells
08/22/1996CA2210538A1 Eukaryotic initiation factor 5a (eif-5a) mutants
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/22/1996CA2209227A1 New chemokines expressed in pancreas
08/22/1996CA2188462A1 Method and composition for regulating apoptosis
08/21/1996EP0727496A2 DNA polymerases
08/21/1996EP0727489A1 DNA sequence coding for an A. thaliana protein with delta-5,7-sterol-delta-7-reductase, the protein, process for the production, transformed yeast-strains and use
08/21/1996EP0727488A1 Glucan elicitor receptor and dna coding for the same
08/21/1996EP0727487A1 Multiple-tumor aberrant growth genes
08/21/1996EP0727486A2 Tumour suppressor gene
08/21/1996EP0727483A2 Retrovirus of the HIV-group and its application
08/21/1996EP0727438A2 Adducts of PEG and GM-CSF
08/21/1996EP0727437A2 Covalent PEG-protein adducts
08/21/1996EP0727434A1 Purification of tissue factor
08/21/1996EP0727046A1 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
08/21/1996EP0726957A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
08/21/1996EP0726955A1 Chimeric proteins comprising borrelia polypeptides: uses therefor
08/21/1996EP0726954A1 Cntf family antagonists
08/21/1996EP0726953A1 Human kunitz-type protease inhibitors
08/21/1996EP0726952A1 Receptor on the surface of activated t-cells:acts-4
08/21/1996EP0726951A1 Manufacture and use of polypeptides tagged using binding molecules
08/21/1996EP0726950A1 Helminth parasite antigen with aminopeptidase-like activity
08/21/1996EP0726949A1 Opioid receptor: compositions and methods
08/21/1996EP0726948A1 Method of inducing and maintaining neuronal cells
08/21/1996EP0726947A1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
08/21/1996EP0726945A1 B1k CHAIN OF LAMININ AND METHODS OF USE
08/21/1996EP0726944A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
08/21/1996EP0726942A1 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use
08/21/1996EP0726914A1 Cell surface protein expressed on human cortical thymocyte and their use
08/21/1996EP0726913A1 Cytokines from natural killer or t cells
08/21/1996EP0726912A1 Cd6 ligand
08/21/1996EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
08/21/1996EP0726910A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds
08/21/1996EP0726909A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726907A1 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
08/21/1996EP0726777A1 Prokaryotic expression of mhc proteins
08/21/1996EP0726776A1 Inhibition of hiv mucosal infection
08/21/1996EP0726774A1 Vaccine design and production
08/21/1996EP0726770A1 Sulfamethoxazole-specific immunosuppressive agents
08/21/1996EP0726767A1 Biochemically active agents for chemical catalysis and cell receptor activation
08/21/1996EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/21/1996EP0726708A1 Virus associated multiple sclerosis: treatments, prevention and diagnosis thereof
08/21/1996EP0726701A1 Salicylic acid binding protein
08/21/1996EP0695307A4 Modified protein and peptide pharmaceuticals
1 ... 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 ... 2916